These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2274750

  • 1. Renal sensitivity to angiotensin II in type 1 diabetes.
    Björck S, Aurell M, Bresäter LE, Herlitz H, Welin L, Wikstrand J.
    Scand J Urol Nephrol; 1990; 24(4):267-73. PubMed ID: 2274750
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.
    Circulation; 2008 Jun 24; 117(25):3199-205. PubMed ID: 18559696
    [Abstract] [Full Text] [Related]

  • 5. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S.
    Transl Res; 2007 Dec 24; 150(6):343-9. PubMed ID: 18022596
    [Abstract] [Full Text] [Related]

  • 6. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.
    Luik PT, Hoogenberg K, Van Der Kleij FG, Beusekamp BJ, Kerstens MN, De Jong PE, Dullaart RP, Navis GJ.
    Diabetologia; 2002 Apr 24; 45(4):535-41. PubMed ID: 12032630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA.
    J Am Soc Nephrol; 2006 Jun 24; 17(6):1703-9. PubMed ID: 16672313
    [Abstract] [Full Text] [Related]

  • 9. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM, Grau C, Furian TC, Wolf S, Braun N, Risler T.
    Clin Nephrol; 1996 Nov 24; 46(5):312-8. PubMed ID: 8953120
    [Abstract] [Full Text] [Related]

  • 10. Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.
    Fioretto P, Sambataro M, Cipollina MG, Duner E, Giorato C, Morocutti A, Mollo F, Ben GP, Carraro A, Sacerdoti D.
    Diabetologia; 1991 Aug 24; 34(8):595-603. PubMed ID: 1936664
    [Abstract] [Full Text] [Related]

  • 11. Physiological actions of angiotensin II on the kidney.
    Freeman RH, Davis JO.
    Fed Proc; 1979 Aug 24; 38(9):2276-9. PubMed ID: 456613
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
    Patinha D, Fasching A, Pinho D, Albino-Teixeira A, Morato M, Palm F.
    Am J Physiol Renal Physiol; 2013 Mar 01; 304(5):F614-22. PubMed ID: 23283998
    [Abstract] [Full Text] [Related]

  • 13. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662.
    Verburg KM, Kleinert HD, Chekal MA, Kadam JR, Young GA.
    J Pharmacol Exp Ther; 1990 Feb 01; 252(2):449-55. PubMed ID: 2179529
    [Abstract] [Full Text] [Related]

  • 14. Renal responses to angiotensin II infusion in early type 1 (insulin-dependent) diabetes.
    Eadington DW, Swainson CP, Frier BM, Semple PF.
    Diabet Med; 1991 Jul 01; 8(6):524-31. PubMed ID: 1832351
    [Abstract] [Full Text] [Related]

  • 15. Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes.
    Fliser D, Wagner KK, Loos A, Tsikas D, Haller H.
    J Am Soc Nephrol; 2005 Apr 01; 16(4):1135-40. PubMed ID: 15716329
    [Abstract] [Full Text] [Related]

  • 16. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G.
    Hypertension; 1983 Apr 01; 5(3):368-74. PubMed ID: 6341220
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
    Hirakata H, Iino K, Ishida I, Kashiwagi M, Yoshinari M, Okuda S, Fujita S, Fujishima M.
    Blood Press Suppl; 1992 Apr 01; 3():124-9. PubMed ID: 1343281
    [Abstract] [Full Text] [Related]

  • 19. Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
    Miller JA, Curtis JR, Sochett EB.
    Diabetes; 2003 Jul 01; 52(7):1806-11. PubMed ID: 12829650
    [Abstract] [Full Text] [Related]

  • 20. Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin-dependent) diabetic patients before and after enalapril treatment.
    Trevisan R, Giorato C, Fioretto P, Orrasch M, Opocher G, Mantero F, Tiengo A, Nosadini R, Pica B, Antonini P.
    J Hypertens Suppl; 1991 Dec 01; 9(6):S390-1. PubMed ID: 1840200
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.